Connect with us

7 Hot Robinhood Penny Stocks to Watch That Could be Pandemic Proof

Which Robinhood penny stocks are on your reopening list?
The post 7 Hot Robinhood Penny Stocks to Watch That Could be Pandemic Proof appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Published

on

7 Robinhood Penny Stocks to Watch For a Pandemic-Related Boost

While the pandemic initially caused major bearish sentiment among penny stocks, since then, many leading small-caps have benefitted. And right now, as the Delta variant takes over, many investors are looking for a list of penny stocks that will grow accordingly. One example of this is retail stocks. These companies have climbed as more people are at-home shopping, and now, beginning to go out to purchase goods once again. Today, Newegg Commerce Inc. (NASDAQ: NEGG) showed just how bullish that momentum can be, pushing up by over 100% at midday. While NEGG stock is just one example, there are plenty to choose from. [Read More] Making a List of Penny Stocks to Buy? Here’s 7 to Watch in Summer 2021 And outside of retail, we have tech stocks, biotech stocks, and energy stocks, that all stand to benefit from both the pandemic and the reopening of the economy. And if we factor in the effects of Robinhood, we see high volatility which can be both a major positive or a negative. So, considering all of this, let’s take a look at some of the best Robinhood penny stocks to watch that could be pandemic proof.

5 Robinhood Penny Stocks to Watch Right Now

  1. Globalstar Inc. (NYSE: GSAT)
  2. Inpixon (NASDAQ: INPX)
  3. ToughBuilt Industries Inc. (NASDAQ: TBLT)
  4. Digital Ally Inc. (NASDAQ: DGLY)
  5. Borr Drilling Ltd. (NYSE: BORR)

Globalstar Inc. (NYSE: GSAT)

Globalstar Inc. is a penny stock that we have discussed frequently in the past few months. This is due to its constant movement and overall popularity in the market. Globalstar is a communications company that provides mobile satellite services. This includes two-way voice and data products such as satellite communications, mobile voice and data services, and more. Its services are used for emergency location, remote business continuity, safety, and more. Additionally, its SPOT retail products such as the SPOT satellite GPS messenger is used for personal tracking and emergency location. On July 1st, Globalstar announced a partnership with FocusPoint International Inc. This partnership is to provide crisis assistance services under the Global Overwatch & Rescue Plan to Globalstar customers. Customers will have access to a team of highly experienced medical, security, and crisis response specialists to address incidents caused by natural disasters and incidents.
“We are so pleased to extend this valuable service to Globalstar customers. Many of our users partake in extreme sports and engage in higher than average travel frequency making this offering a service that can help further improve our customers’ peace of mind. FocusPoint provides a comprehensive risk consulting service that is a great compliment to the connectivity we provide our customers.” CEO of Globalstar, David Kagan
Globalstar’s interesting market position and continuous momentum shows just how popular it is right now. Considering this and based on this new advancement will GSAT stock make your watchlist this week?
Penny_Stocks_to_Watch_Globalstar_Inc._(GSAT_Stock_Chart)

Inpixon (NASDAQ: INPX)

One tech penny stock that has been performing well in the past few weeks is Inpixon. This company provides big data analytics and location-based products. Its Inpixon Sensor 4000 product is a passive RF sensor to detect signals ranging from pings to a cell tower, to active wireless transmissions. Inpixon also offers data analytics solutions such as IPA Wi-Fi, which is a cloud-based data analytics engine for visitor metrics and insights. It does so by ingesting diverse data from IoT, third-party, and proprietary sensors. [Read More] Hot Small-Cap Stocks To Watch With Potential Cancer Breakthroughs The latest update from Inpixon came from June 28th. This is when the company announced that it has been added to the Russell Microcap Index. The addition to the index took place after the markets opened on June 28th, 2021.
“We are pleased to be included in the Russell Microcap Index. We believe this addition is reflective of our continued growth over the past year as we completed meaningful acquisitions and enhanced our Indoor Intelligence platform. [We] also added our smart office app with The CXApp acquisition which is being used by large enterprises to facilitate safe office re-openings, desk bookings, employee engagement, and hybrid events.”CEO of Inpixon, Nadir Al
This event caused INPX stock price to spike, however, it quickly corrected, and most do when big news is announced. While trading has been very mixed for INPX in the past year, it does have a lot to offer investors. So keeping this information in mind, will you add INPX stock to your watchlist in 2021?
Penny_Stocks_to_Watch_Inpixon_

ToughBuilt Industries Inc. (NASDAQ: TBLT)

ToughBuilt Industries Inc. is an industrial company that designs, develops, manufactures, and distributes home improvement and construction products. These products are sold to those in the construction and retail home improvement industry. It offers tool pouches, tool rigs, tool bags, and many more products for personal use. It also offers miter saws, table saws, roller stands, and other job site offerings. The latest update from ToughBuilt comes from May of this year. This is when the company released its first-quarter financial results for 2021. The company experienced 214% in revenue growth year over year to $12.3 million. This is due to the increase in home improvement that has occurred during the pandemic.
“The strategic investments we’ve made in research and development, coupled with our manufacturing and distribution capabilities, continue to pay off, which translated into significant revenue growth and a robust backlog coming out of the first quarter of 2021.” The CEO of TBLT, Michael Panosian
TBLT stock has been increasing in the market recently. Its volume is also much higher than its average. With this in mind, will TBLT make your list of penny stocks to watch?
Penny_Stocks_to_Watch_ToughBuilt_Industries_Inc_TBLT_Stock_Chart

Digital Ally Inc. (NASDAQ: DGLY)

Digital Ally Inc. is an industrial stock that produces and sells digital video imaging, storage, and disinfectant. These safety products are in use in law enforcement, security, and more. It offers in-car digital video mirror systems for law enforcement, bodycams, and much more. [Read More] 7 Penny Stocks For Your Watch List This Week If You Like Biotech In July In the past, Digital Ally has transitioned its business to wherever it is needed. This is a solid strategy and one that is paying off as seen in its most recent announcements. On June 7th the company formed a new business unit to pursue healthcare market opportunities. The company has contributed $13.5 million of capital to this venture. The
“Last year we added the Shield Health Protection Products line to address parts of the health and wellness market. The Shield line includes Shield Cleansers, a highly effective, yet safe, disinfectant and sanitizer for use against SARS-CoV-2, a non-contact thermometer/controlled-entry device, an electrostatic sprayer for fast and efficient disinfecting of large areas, and a variety of personal protective equipment including face masks, gloves, and sanitizer wipes.” CEO of Digital Ally Stan Ross
Because of Digital Ally’s ties to fighting COVID-19, it continues to catch attention from investors. And, with cases increasing again in specific parts of the country, many believe that the need for its products could increase. Whether this makes DGLY worth adding to your watchlist is up to you.
Penny_Stocks_to_Watch_Digital_Ally_Inc._(DGLY_Stock_Chart)

Borr Drilling Limited (NYSE: BORR)

Borr Drilling Limited is an oil and gas penny stock that provides offshore drilling. The company owns, contracts, and operates jack-up rigs for operations in shallow water areas. It serves oil and gas exploration and production companies, such as independent and state-owned oil companies. As of December 31st, 2020 the company had a fleet of 24 jack-up drilling rigs. And on July 6th the company announced an at-the-market offering of up to $40 million. This should help to fund a large number of future endeavors, as capital is extremely important to the energy industry. Other than this, there have not been any recent updates from Borr Drilling. Yet on July 6th, the company’s stock price went up by 0.42%. Its volume is also higher than its average at the moment. As many oil and gas penny stocks are performing well, it seems like BORR stock is benefitting from the increased demand for energy right now. The company has gone down in price over the last month but there have been several spikes since then. Considering these exciting factors, will BORR make your penny stock watchlist?
Penny_Stocks_to_Watch_Borr_Drilling_Limited_BORR_Stock_Chart

2 More Robinhood Penny Stocks to Watch Right Now

  1. Dare Bioscience Inc. (NASDAQ: DARE)
  2. Lion Group Holding Ltd. ADR (NASDAQ: LGHL)

Robinhood Penny Stocks Continue to Show Momentum

There’s a reason that so many investors choose to buy penny stocks on Robinhood. With no commission trading and an intuitive platform, it has become the choice brokerage for all types of retail investors. [Read More] Hot Robinhood Penny Stocks to Buy Right Now? 10 To Know About Granted, there are plenty of brokerages out there to choose from, but Robinhood is extremely popular. And, it has opened up the world of investing to a new breed of trader; one that usually follows popular trends and one with a disregard for institutional trading. Considering all of this, which penny stocks are on your watchlist right now? The post 7 Hot Robinhood Penny Stocks to Watch That Could be Pandemic Proof appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

Continue Reading

Government

CDC Warns Thousands Of Children Sent To ER After Taking Common Sleep Aid

CDC Warns Thousands Of Children Sent To ER After Taking Common Sleep Aid

Authored by Jack Phillips via The Epoch Times (emphasis ours),

A…

Published

on

CDC Warns Thousands Of Children Sent To ER After Taking Common Sleep Aid

Authored by Jack Phillips via The Epoch Times (emphasis ours),

A U.S. Centers for Disease Control (CDC) paper released Thursday found that thousands of young children have been taken to the emergency room over the past several years after taking the very common sleep-aid supplement melatonin.

The Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia, on April 23, 2020. (Tami Chappell/AFP via Getty Images)

The agency said that melatonin, which can come in gummies that are meant for adults, was implicated in about 7 percent of all emergency room visits for young children and infants “for unsupervised medication ingestions,” adding that many incidents were linked to the ingestion of gummy formulations that were flavored. Those incidents occurred between the years 2019 and 2022.

Melatonin is a hormone produced by the human body to regulate its sleep cycle. Supplements, which are sold in a number of different formulas, are generally taken before falling asleep and are popular among people suffering from insomnia, jet lag, chronic pain, or other problems.

The supplement isn’t regulated by the U.S. Food and Drug Administration and does not require child-resistant packaging. However, a number of supplement companies include caps or lids that are difficult for children to open.

The CDC report said that a significant number of melatonin-ingestion cases among young children were due to the children opening bottles that had not been properly closed or were within their reach. Thursday’s report, the agency said, “highlights the importance of educating parents and other caregivers about keeping all medications and supplements (including gummies) out of children’s reach and sight,” including melatonin.

The approximately 11,000 emergency department visits for unsupervised melatonin ingestions by infants and young children during 2019–2022 highlight the importance of educating parents and other caregivers about keeping all medications and supplements (including gummies) out of children’s reach and sight.

The CDC notes that melatonin use among Americans has increased five-fold over the past 25 years or so. That has coincided with a 530 percent increase in poison center calls for melatonin exposures to children between 2012 and 2021, it said, as well as a 420 percent increase in emergency visits for unsupervised melatonin ingestion by young children or infants between 2009 and 2020.

Some health officials advise that children under the age of 3 should avoid taking melatonin unless a doctor says otherwise. Side effects include drowsiness, headaches, agitation, dizziness, and bed wetting.

Other symptoms of too much melatonin include nausea, diarrhea, joint pain, anxiety, and irritability. The supplement can also impact blood pressure.

However, there is no established threshold for a melatonin overdose, officials have said. Most adult melatonin supplements contain a maximum of 10 milligrams of melatonin per serving, and some contain less.

Many people can tolerate even relatively large doses of melatonin without significant harm, officials say. But there is no antidote for an overdose. In cases of a child accidentally ingesting melatonin, doctors often ask a reliable adult to monitor them at home.

Dr. Cora Collette Breuner, with the Seattle Children’s Hospital at the University of Washington, told CNN that parents should speak with a doctor before giving their children the supplement.

“I also tell families, this is not something your child should take forever. Nobody knows what the long-term effects of taking this is on your child’s growth and development,” she told the outlet. “Taking away blue-light-emitting smartphones, tablets, laptops, and television at least two hours before bed will keep melatonin production humming along, as will reading or listening to bedtime stories in a softly lit room, taking a warm bath, or doing light stretches.”

In 2022, researchers found that in 2021, U.S. poison control centers received more than 52,000 calls about children consuming worrisome amounts of the dietary supplement. That’s a six-fold increase from about a decade earlier. Most such calls are about young children who accidentally got into bottles of melatonin, some of which come in the form of gummies for kids, the report said.

Dr. Karima Lelak, an emergency physician at Children’s Hospital of Michigan and the lead author of the study published in 2022 by the CDC, found that in about 83 percent of those calls, the children did not show any symptoms.

However, other children had vomiting, altered breathing, or other symptoms. Over the 10 years studied, more than 4,000 children were hospitalized, five were put on machines to help them breathe, and two children under the age of two died. Most of the hospitalized children were teenagers, and many of those ingestions were thought to be suicide attempts.

Those researchers also suggested that COVID-19 lockdowns and virtual learning forced more children to be at home all day, meaning there were more opportunities for kids to access melatonin. Also, those restrictions may have caused sleep-disrupting stress and anxiety, leading more families to consider melatonin, they suggested.

The Associated Press contributed to this report.

Tyler Durden Mon, 03/11/2024 - 21:40

Read More

Continue Reading

International

Red Candle In The Wind

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by…

Published

on

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by printing at 275,000 against a consensus call of 200,000. We say superficially, because the downward revisions to prior months totalled 167,000 for December and January, taking the total change in employed persons well below the implied forecast, and helping the unemployment rate to pop two-ticks to 3.9%. The U6 underemployment rate also rose from 7.2% to 7.3%, while average hourly earnings growth fell to 0.2% m-o-m and average weekly hours worked languished at 34.3, equalling pre-pandemic lows.

Undeterred by the devil in the detail, the algos sprang into action once exchanges opened. Market darling NVIDIA hit a new intraday high of $974 before (presumably) the humans took over and sold the stock down more than 10% to close at $875.28. If our suspicions are correct that it was the AIs buying before the humans started selling (no doubt triggering trailing stops on the way down), the irony is not lost on us.

The 1-day chart for NVIDIA now makes for interesting viewing, because the red candle posted on Friday presents quite a strong bearish engulfing signal. Volume traded on the day was almost double the 15-day simple moving average, and similar price action is observable on the 1-day charts for both Intel and AMD. Regular readers will be aware that we have expressed incredulity in the past about the durability the AI thematic melt-up, so it will be interesting to see whether Friday’s sell off is just a profit-taking blip, or a genuine trend reversal.

AI equities aside, this week ought to be important for markets because the BTFP program expires today. That means that the Fed will no longer be loaning cash to the banking system in exchange for collateral pledged at-par. The KBW Regional Banking index has so far taken this in its stride and is trading 30% above the lows established during the mini banking crisis of this time last year, but the Fed’s liquidity facility was effectively an exercise in can-kicking that makes regional banks a sector of the market worth paying attention to in the weeks ahead. Even here in Sydney, regulators are warning of external risks posed to the banking sector from scheduled refinancing of commercial real estate loans following sharp falls in valuations.

Markets are sending signals in other sectors, too. Gold closed at a new record-high of $2178/oz on Friday after trading above $2200/oz briefly. Gold has been going ballistic since the Friday before last, posting gains even on days where 2-year Treasury yields have risen. Gold bugs are buying as real yields fall from the October highs and inflation breakevens creep higher. This is particularly interesting as gold ETFs have been recording net outflows; suggesting that price gains aren’t being driven by a retail pile-in. Are gold buyers now betting on a stagflationary outcome where the Fed cuts without inflation being anchored at the 2% target? The price action around the US CPI release tomorrow ought to be illuminating.

Leaving the day-to-day movements to one side, we are also seeing further signs of structural change at the macro level. The UK budget last week included a provision for the creation of a British ISA. That is, an Individual Savings Account that provides tax breaks to savers who invest their money in the stock of British companies. This follows moves last year to encourage pension funds to head up the risk curve by allocating 5% of their capital to unlisted investments.

As a Hail Mary option for a government cruising toward an electoral drubbing it’s a curious choice, but it’s worth highlighting as cash-strapped governments increasingly see private savings pools as a funding solution for their spending priorities.

Of course, the UK is not alone in making creeping moves towards financial repression. In contrast to announcements today of increased trade liberalisation, Australian Treasurer Jim Chalmers has in the recent past flagged his interest in tapping private pension savings to fund state spending priorities, including defence, public housing and renewable energy projects. Both the UK and Australia appear intent on finding ways to open up the lungs of their economies, but government wants more say in directing private capital flows for state goals.

So, how far is the blurring of the lines between free markets and state planning likely to go? Given the immense and varied budgetary (and security) pressures that governments are facing, could we see a re-up of WWII-era Victory bonds, where private investors are encouraged to do their patriotic duty by directly financing government at negative real rates?

That would really light a fire under the gold market.

Tyler Durden Mon, 03/11/2024 - 19:00

Read More

Continue Reading

Government

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Mandating COVID-19…

Published

on

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Mandating COVID-19 vaccination was a mistake due to ethical and other concerns, a top government doctor warned Dr. Anthony Fauci after Dr. Fauci promoted mass vaccination.

Coercing or forcing people to take a vaccine can have negative consequences from a biological, sociological, psychological, economical, and ethical standpoint and is not worth the cost even if the vaccine is 100% safe,” Dr. Matthew Memoli, director of the Laboratory of Infectious Diseases clinical studies unit at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), told Dr. Fauci in an email.

“A more prudent approach that considers these issues would be to focus our efforts on those at high risk of severe disease and death, such as the elderly and obese, and do not push vaccination on the young and healthy any further.”

Dr. Anthony Fauci, ex-director of the National Institute of Allergy and Infectious Diseases (NIAID. in Washington on Jan. 8, 2024. (Madalina Vasiliu/The Epoch Times)

Employing that strategy would help prevent loss of public trust and political capital, Dr. Memoli said.

The email was sent on July 30, 2021, after Dr. Fauci, director of the NIAID, claimed that communities would be safer if more people received one of the COVID-19 vaccines and that mass vaccination would lead to the end of the COVID-19 pandemic.

“We’re on a really good track now to really crush this outbreak, and the more people we get vaccinated, the more assuredness that we’re going to have that we’re going to be able to do that,” Dr. Fauci said on CNN the month prior.

Dr. Memoli, who has studied influenza vaccination for years, disagreed, telling Dr. Fauci that research in the field has indicated yearly shots sometimes drive the evolution of influenza.

Vaccinating people who have not been infected with COVID-19, he said, could potentially impact the evolution of the virus that causes COVID-19 in unexpected ways.

“At best what we are doing with mandated mass vaccination does nothing and the variants emerge evading immunity anyway as they would have without the vaccine,” Dr. Memoli wrote. “At worst it drives evolution of the virus in a way that is different from nature and possibly detrimental, prolonging the pandemic or causing more morbidity and mortality than it should.”

The vaccination strategy was flawed because it relied on a single antigen, introducing immunity that only lasted for a certain period of time, Dr. Memoli said. When the immunity weakened, the virus was given an opportunity to evolve.

Some other experts, including virologist Geert Vanden Bossche, have offered similar views. Others in the scientific community, such as U.S. Centers for Disease Control and Prevention scientists, say vaccination prevents virus evolution, though the agency has acknowledged it doesn’t have records supporting its position.

Other Messages

Dr. Memoli sent the email to Dr. Fauci and two other top NIAID officials, Drs. Hugh Auchincloss and Clifford Lane. The message was first reported by the Wall Street Journal, though the publication did not publish the message. The Epoch Times obtained the email and 199 other pages of Dr. Memoli’s emails through a Freedom of Information Act request. There were no indications that Dr. Fauci ever responded to Dr. Memoli.

Later in 2021, the NIAID’s parent agency, the U.S. National Institutes of Health (NIH), and all other federal government agencies began requiring COVID-19 vaccination, under direction from President Joe Biden.

In other messages, Dr. Memoli said the mandates were unethical and that he was hopeful legal cases brought against the mandates would ultimately let people “make their own healthcare decisions.”

“I am certainly doing everything in my power to influence that,” he wrote on Nov. 2, 2021, to an unknown recipient. Dr. Memoli also disclosed that both he and his wife had applied for exemptions from the mandates imposed by the NIH and his wife’s employer. While her request had been granted, his had not as of yet, Dr. Memoli said. It’s not clear if it ever was.

According to Dr. Memoli, officials had not gone over the bioethics of the mandates. He wrote to the NIH’s Department of Bioethics, pointing out that the protection from the vaccines waned over time, that the shots can cause serious health issues such as myocarditis, or heart inflammation, and that vaccinated people were just as likely to spread COVID-19 as unvaccinated people.

He cited multiple studies in his emails, including one that found a resurgence of COVID-19 cases in a California health care system despite a high rate of vaccination and another that showed transmission rates were similar among the vaccinated and unvaccinated.

Dr. Memoli said he was “particularly interested in the bioethics of a mandate when the vaccine doesn’t have the ability to stop spread of the disease, which is the purpose of the mandate.”

The message led to Dr. Memoli speaking during an NIH event in December 2021, several weeks after he went public with his concerns about mandating vaccines.

“Vaccine mandates should be rare and considered only with a strong justification,” Dr. Memoli said in the debate. He suggested that the justification was not there for COVID-19 vaccines, given their fleeting effectiveness.

Julie Ledgerwood, another NIAID official who also spoke at the event, said that the vaccines were highly effective and that the side effects that had been detected were not significant. She did acknowledge that vaccinated people needed boosters after a period of time.

The NIH, and many other government agencies, removed their mandates in 2023 with the end of the COVID-19 public health emergency.

A request for comment from Dr. Fauci was not returned. Dr. Memoli told The Epoch Times in an email he was “happy to answer any questions you have” but that he needed clearance from the NIAID’s media office. That office then refused to give clearance.

Dr. Jay Bhattacharya, a professor of health policy at Stanford University, said that Dr. Memoli showed bravery when he warned Dr. Fauci against mandates.

“Those mandates have done more to demolish public trust in public health than any single action by public health officials in my professional career, including diminishing public trust in all vaccines.” Dr. Bhattacharya, a frequent critic of the U.S. response to COVID-19, told The Epoch Times via email. “It was risky for Dr. Memoli to speak publicly since he works at the NIH, and the culture of the NIH punishes those who cross powerful scientific bureaucrats like Dr. Fauci or his former boss, Dr. Francis Collins.”

Tyler Durden Mon, 03/11/2024 - 17:40

Read More

Continue Reading

Trending